MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹90 Cr | ₹44 Cr | ₹37 Cr | ₹35 Cr | ₹30 Cr |
What is the latest Total Non-Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹90 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹30 Cr |
How is Total Non-Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹90 Cr | 105.96 | |
| Mar2024 | ₹44 Cr | 19.11 | |
| Mar2023 | ₹37 Cr | 3.91 | |
| Mar2022 | ₹35 Cr | 18.10 | |
| Mar2021 | ₹30 Cr | - | |
Compare Total Non-Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,947.7 Cr | -7.6% | 3.3% | -17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -7.6% |
3.3% |
-17% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses